FY2025 EPS Estimates for Revvity Lifted by Zacks Research

Revvity Inc. (NYSE:RVTY) – Stock analysts at Zacks Research increased their FY2025 earnings estimates for Revvity in a research note issued to investors on Monday, November 17th. Zacks Research analyst Team now anticipates that the company will post earnings of $4.91 per share for the year, up from their prior estimate of $4.86. The consensus estimate for Revvity’s current full-year earnings is $4.94 per share. Zacks Research also issued estimates for Revvity’s Q4 2025 earnings at $1.54 EPS, Q1 2026 earnings at $1.13 EPS, Q2 2026 earnings at $1.30 EPS, Q3 2026 earnings at $1.29 EPS, Q4 2026 earnings at $1.58 EPS, FY2026 earnings at $5.30 EPS, Q1 2027 earnings at $1.29 EPS, Q2 2027 earnings at $1.51 EPS, Q3 2027 earnings at $1.49 EPS and FY2027 earnings at $6.00 EPS.

Revvity (NYSE:RVTY) last announced its quarterly earnings results on Monday, October 27th. The company reported $1.18 EPS for the quarter, topping the consensus estimate of $1.14 by $0.04. Revvity had a return on equity of 7.52% and a net margin of 8.44%.The business had revenue of $698.95 million for the quarter, compared to analyst estimates of $699.75 million. During the same quarter in the previous year, the company earned $1.28 EPS. The company’s quarterly revenue was up 2.2% on a year-over-year basis. Revvity has set its FY 2025 guidance at 4.900-5.000 EPS.

Several other research firms have also recently issued reports on RVTY. Weiss Ratings restated a “sell (d)” rating on shares of Revvity in a report on Thursday. Raymond James Financial restated an “outperform” rating and issued a $115.00 price target (down previously from $120.00) on shares of Revvity in a report on Tuesday, July 29th. Robert W. Baird increased their price target on shares of Revvity from $122.00 to $123.00 and gave the stock an “outperform” rating in a research note on Tuesday, October 28th. Bank of America decreased their price target on shares of Revvity from $110.00 to $99.00 and set a “buy” rating on the stock in a report on Monday, September 22nd. Finally, Guggenheim assumed coverage on Revvity in a report on Wednesday, October 15th. They set a “neutral” rating for the company. Eight investment analysts have rated the stock with a Buy rating, five have issued a Hold rating and one has issued a Sell rating to the stock. According to data from MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and an average target price of $114.75.

Revvity Trading Down 1.9%

NYSE:RVTY opened at $91.01 on Tuesday. The company has a quick ratio of 2.75, a current ratio of 1.75 and a debt-to-equity ratio of 0.36. Revvity has a 52-week low of $81.36 and a 52-week high of $128.29. The company has a market capitalization of $10.32 billion, a PE ratio of 45.73, a price-to-earnings-growth ratio of 3.15 and a beta of 1.01. The stock has a fifty day simple moving average of $90.60 and a 200-day simple moving average of $92.22.

Revvity Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Friday, February 6th. Stockholders of record on Friday, January 16th will be given a $0.07 dividend. The ex-dividend date of this dividend is Friday, January 16th. This represents a $0.28 annualized dividend and a dividend yield of 0.3%. Revvity’s payout ratio is presently 14.07%.

Revvity declared that its board has approved a stock buyback plan on Monday, October 27th that authorizes the company to buyback $1.00 billion in shares. This buyback authorization authorizes the company to purchase up to 8.7% of its shares through open market purchases. Shares buyback plans are usually a sign that the company’s management believes its shares are undervalued.

Institutional Inflows and Outflows

Large investors have recently bought and sold shares of the company. Family Legacy Financial Solutions LLC acquired a new stake in shares of Revvity during the second quarter worth $5,351,000. Czech National Bank boosted its holdings in shares of Revvity by 3.1% in the 2nd quarter. Czech National Bank now owns 28,811 shares of the company’s stock valued at $2,787,000 after buying an additional 858 shares during the period. LPL Financial LLC grew its position in shares of Revvity by 9.9% during the 1st quarter. LPL Financial LLC now owns 29,982 shares of the company’s stock valued at $3,172,000 after buying an additional 2,702 shares during the last quarter. Aviva PLC raised its stake in Revvity by 5.0% during the second quarter. Aviva PLC now owns 89,527 shares of the company’s stock worth $8,659,000 after acquiring an additional 4,303 shares during the period. Finally, Patton Fund Management Inc. bought a new position in Revvity in the second quarter worth about $226,000. Institutional investors own 86.65% of the company’s stock.

About Revvity

Revvity, Inc provides health sciences solutions, technologies, and services in the Americas, Europe, and Asia, and internationally. The Life Sciences segment provides instruments, reagents, informatics, software, subscriptions, detection, imaging technologies, warranties, training, and services. Its Diagnostics segment provides instruments, reagents, assay platforms, and software products for the early detection of genetic disorders, such as pregnancy and early childhood, as well as infectious disease testing in the diagnostics market.